HRS-2129
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for HRS-2129, covering 2025-03-05 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain [Phase 1]